What is the minimum working area requirement for a Central Intravenous Admixture Service (CIVAS)?

What is the minimum working area requirement for a Central Intravenous Admixture Service (CIVAS)?

• A. 36 square feet
• B. 72 square feet
• C. 100 square feet
• D. 120 square feet

Answer: (B)

The minimum working area requirement for a Central Intravenous Admixture Service (CIVAS) is 72 square feet. This requirement is established to ensure that there is adequate space for the safe preparation of intravenous medications without compromising sterility or safety standards. A workspace of this size allows for proper equipment placement, the organization of supplies, and sufficient room for personnel to operate efficiently without overcrowding. Having an adequate working area is crucial in a sterile compounding environment, where contamination is a major concern. A space that is too small can lead to hazards, increase the risk of error, and impede the ability to maintain cleanliness. The 72 square feet requirement is designed to facilitate compliance with established guidelines and best practices in pharmacy operations, particularly those that involve aseptic techniques essential for preparing intravenous admixtures. In contrast, other options that present higher or lower specifications do not align with established regulatory standards, which specifically call for this minimum to ensure safety and efficiency in the compounding process.

The minimum working area requirement for a Central Intravenous Admixture Service (CIVAS) is 72 square feet. This requirement is established to ensure that there is adequate space for the safe preparation of intravenous medications without compromising sterility or safety standards. A workspace of this size allows for proper equipment placement, the organization of supplies, and sufficient room for personnel to operate efficiently without overcrowding.

Having an adequate working area is crucial in a sterile compounding environment, where contamination is a major concern. A space that is too small can lead to hazards, increase the risk of error, and impede the ability to maintain cleanliness. The 72 square feet requirement is designed to facilitate compliance with established guidelines and best practices in pharmacy operations, particularly those that involve aseptic techniques essential for preparing intravenous admixtures.

In contrast, other options that present higher or lower specifications do not align with established regulatory standards, which specifically call for this minimum to ensure safety and efficiency in the compounding process.